850,000 Shares in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Acquired by Decheng Capital LLC wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
27,429 Shares in argenx SE (NASDAQ:ARGX) Acquired by Decheng Capital LLC modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Acquisition transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025
Acquisition adds taletrectinib, a next-generation,.
Nuvation Bio Inc. entered into an Agreement and Plan of Merger to acquire AnHeart Therapeutics Ltd. on March 24, 2024. Nuvation Bio entered into a definitive agreement for Nuvation Bio to acquire.